Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Akttyva Therapeutics speeds discovery of targeted treatments for diseases caused by vascular leakage. The company uses an AI-assisted drug-discovery platform, AIDE-360, that combines machine…

Akttyva Therapeutics speeds discovery of targeted treatments for diseases caused by vascular leakage. The company uses an AI-assisted drug-discovery platform, AIDE-360, that combines machine…
Headquarters: Mansfield / Watertown, Massachusetts
Focus: AI-assisted drug discovery for vascular leakage / cell barrier dysfunction
Platform: AIDE-360 (ML, neural nets, cheminformatics, physics-based methods + experimental validation)
Funding type: Grant / accelerator support (NSF, MassChallenge)
Discovery and development of targeted therapeutics addressing cell barrier dysfunction / vascular leakage
2020
Biotechnology
Non-dilutive accelerator support reported
260000 USD
NSF grant funding (reported as SBIR/Phase award)
“Grant and accelerator support from the U.S. National Science Foundation and MassChallenge”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week
| Company |
|---|